Shostka G D
Ter Arkh. 1987;59(8):97-102.
Hemorrhage values and the amount of iron entering the body with drugs and blood transfusions were determined in 107 patients with the terminal CRF stage. Of them 59 received regular hemodialyses. The level of serum iron and ferritin as well as iron reserves in the body were investigated at the start and end of the study. In the end a histochemical study of the content of hemosiderin in the bone marrow, liver and spleen was performed. A close interrelationship of iron reserves determined with a modified desferal test and the level of serum ferritin (r = 0.94) was established. The highest iron reserves were revealed in the patients receiving blood transfusions and parenteral iron drugs. Criteria for the assessment of iron reserves in patients with renal failure were determined by means of the modified desferal test and investigation of serum ferritin. Normal ferritin reserves in such patients corresponded to serum ferritin values within the range of 50-400 micrograms/l and indices of the modified desferal test ranging from 0.4 to 2.0/0.5 g of desferal. Of a degree of hemosiderosis one could judge on the basis of a histochemical investigation of tissue hemosiderin only. Iron drugs per os were proposed for the prevention of disorders of iron balance in patients with renal failure.
测定了107例终末期慢性肾衰竭患者的出血值以及通过药物和输血进入体内的铁量。其中59例接受定期血液透析。在研究开始和结束时,对血清铁、铁蛋白水平以及体内铁储备进行了调查。最后,对骨髓、肝脏和脾脏中的含铁血黄素含量进行了组织化学研究。通过改良去铁胺试验测定的铁储备与血清铁蛋白水平之间建立了密切的相关性(r = 0.94)。接受输血和胃肠外铁剂治疗的患者铁储备最高。通过改良去铁胺试验和血清铁蛋白检测确定了评估肾衰竭患者铁储备的标准。此类患者正常的铁蛋白储备对应于血清铁蛋白值在50 - 400微克/升范围内,改良去铁胺试验指标为每0.5克去铁胺0.4至2.0。只能根据组织含铁血黄素的组织化学研究来判断含铁血黄素沉着症的程度。建议口服铁剂预防肾衰竭患者的铁平衡紊乱。